Bumetanide Injection, USP Principal Display Panel | Pfizer Medical Information

If you provide additional keywords, you may be able to browse through our database of Scientific Response Documents.

Our scientific content is evidence-based, scientifically balanced and non-promotional. It undergoes rigorous internal medical review and is updated regularly to reflect new information.

PRINCIPAL DISPLAY PANEL - 4 mL Vial Label

4 mL
Single-dose Vial

NDC 0409-1412-34
Rx only

Bumetanide
Injection, USP

1 mg/4 mL (0.25 mg/mL)

INTRAVENOUS or
INTRAMUSCULAR USE

PRINCIPAL DISPLAY PANEL - 4 mL Vial Label

PRINCIPAL DISPLAY PANEL - 4 mL Vial Box

4 mL 10 Single-dose Vials
Sterile Injection

NDC 0409-1412-04
Contains 10 of NDC 0409-1412-34
Rx only

Bumetanide Injection, USP

1 mg/4 mL (0.25 mg/mL)

INTRAVENOUS or INTRAMUSCULAR USE

Hospira

PRINCIPAL DISPLAY PANEL - 10 mL Vial Label

10 mL
Multi-dose Vial

NDC 0409-1412-40
Rx only

Bumetanide
Injection, USP

2.5 mg/10 mL
(0.25 mg/mL)

INTRAVENOUS or INTRAMUSCULAR USE
Protect from light.

Distributed by Hospira, Inc.
Lake Forest, IL 60045 USA

Hospira

PRINCIPAL DISPLAY PANEL - 10 mL Vial Label

PRINCIPAL DISPLAY PANEL - 10 mL Vial Box

10 mL 10 Multi-dose Vials
Sterile Injection

NDC 0409-1412-10
Contains 10 of NDC 0409-1412-40
Rx only

Bumetanide Injection, USP

2.5 mg/10 mL (0.25 mg/mL)

INTRAVENOUS or INTRAMUSCULAR USE

Hospira

PRINCIPAL DISPLAY PANEL - 10 mL Vial Box

If you provide additional keywords, you may be able to browse through our database of Scientific Response Documents.

Our scientific content is evidence-based, scientifically balanced and non-promotional. It undergoes rigorous internal medical review and is updated regularly to reflect new information.

Bumetanide Injection, USP Quick Finder

Pfizer samples (for eligible HCPs)

Requests for samples of prescription medications can be made by contacting Pfizer for Professionals at 1-800-505-4426 or by visiting the PfizerPro website www.pfizerpro.com.
Report an adverse event or concern about the quality of a Pfizer product

To report an adverse event related to a Pfizer product and you are not part of a clinical trial* for this product, click the link below to submit your information: Pfizer Safety Reporting Site

*If you are involved in a clinical trial for either product, adverse events should be reported to your coordinating study site.

If you cannot use the above website to report an adverse event related to a Pfizer product, please call Pfizer Medical Information at (800) 438-1985.

If you prefer, you may contact the U.S. Food and Drug Administration (FDA) directly by visiting www.fda.gov/medwatch or by calling (800)-332-1088.
Assistance programs (for eligible patients)

Pfizer RxPathways connects eligible patients to a range of assistance programs that offer insurance support, co-pay help, and medicines for free or at a savings. Patients and physicians can contact RxPathways at (866) 706-2400 or visit the website for more information on these programs www.pfizerrxpathways.com.
Resources

Show All Hide All

WARNING

Bumetanide injection is a potent diuretic which, if given in excessive amounts, can lead to a profound diuresis with water and electrolyte depletion. Therefore, careful medical supervision is required, and dose and dosage schedule have to be...